We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
O-I Glass
OI
$1.39B
| $1.33M | 0.02% |
57,078
-4,050
| -7% | -$99.2K |
|
527
Colgate-Palmolive
CL
$72.6B
| $1.32M | 0.02% |
19,075
+11,155
| +141% | +$771K |
|
|
HSNI
528
DELISTED
HSN, Inc.
HSNI
| $1.32M | 0.02% |
19,375
-177,432
| -90% | -$12.5M |
|
|
OWW
529
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $1.32M | 0.02% |
113,409
-89,620
| -44% | -$947K |
|
530
Avanos Medical
AVNS
$1.17B
| $1.32M | 0.02% |
26,796
-241,157
| -90% | -$11.2M |
|
|
ESL
531
DELISTED
Esterline Technologies
ESL
| $1.31M | 0.02% |
+11,482
| New | +$1.3M |
|
532
Plains GP Holdings
PAGP
$5.23B
| $1.31M | 0.02% |
17,292
| – | – |
|
533
PTC Therapeutics
PTCT
$6.37B
| $1.28M | 0.02% |
21,095
+278
| +1% | +$17K |
|
534
Ametek
AME
$55.5B
| $1.27M | 0.02% |
+24,202
| New | +$1.24M |
|
|
ADVS
535
DELISTED
Advent Software Inc
ADVS
| $1.27M | 0.02% |
28,843
-100,014
| -78% | -$4.12M |
|
|
INXN
536
DELISTED
Interxion Holding N.V.
INXN
| $1.27M | 0.02% |
+45,000
| New | +$1.32M |
|
|
DISH
537
DELISTED
DISH Network Corp.
DISH
| $1.26M | 0.02% |
18,058
-1,488
| -8% | -$110K |
|
538
Edwards Lifesciences
EW
$47.6B
| $1.26M | 0.02% |
53,040
+41,064
| +343% | +$921K |
|
539
Ford
F
$57.3B
| $1.26M | 0.02% |
78,024
+59,200
| +314% | +$934K |
|
|
SCU
540
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.25M | 0.02% |
9,856
-5,543
| -36% | -$666K |
|
541
Walt Disney
DIS
$165B
| $1.23M | 0.02% |
+11,708
| New | +$1.18M |
|
542
Alto Ingredients
ALTO
$360M
| $1.22M | 0.02% |
113,180
-319,523
| -74% | -$3.08M |
|
543
Skyworks Solutions
SWKS
$9.06B
| $1.22M | 0.02% |
12,417
-36,047
| -74% | -$3.08M |
|
|
LNKD
544
DELISTED
LinkedIn Corporation
LNKD
| $1.21M | 0.02% |
4,835
-25,868
| -84% | -$6.42M |
|
545
Zillow
ZG
$7.02B
| $1.21M | 0.02% |
+36,066
| New | +$1.27M |
|
546
Akamai
AKAM
$16.8B
| $1.2M | 0.02% |
16,903
-200,739
| -92% | -$13.3M |
|
547
Radian Group
RDN
$5.14B
| $1.2M | 0.02% |
71,492
| – | – |
|
548
Paylocity
PCTY
$6.71B
| $1.18M | 0.02% |
41,335
-245,728
| -86% | -$6.76M |
|
|
KKD
549
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $1.18M | 0.02% |
59,266
+13,807
| +30% | +$281K |
|
|
TXNM
550
TXNM Energy Inc
TXNM
$6.47B
| $1.18M | 0.02% |
40,269
+8,505
| +27% | +$248K |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.